Sanofi ADR (SNY)

52.08 -0.09 (-0.17%)
Closed USD Disclaimer
52.08 -0.00 (-0.00%)

SNY Financial Summary

For the six months ended 30 September 2021, SanofiSA (ADR) revenues increased 3% to EUR19.72B. Net incomeincreased 7% to EUR3.88B. Revenues reflectVaccines-Influenza Vaccines segment increase of 26% toEUR1.42B, Consumer Healthcare-Digestive segment increase of28% to EUR565M, United States segment increase of 6% toEUR7.37B, China segment increase of 13% to EUR1.51B, Europesegment increase of 1% to EUR4.71B.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
SNY
Gross margin TTM 68.26%
Operating margin TTM 21.21%
Net Profit margin TTM 16.12%
Return on Investment TTM -
Total Revenue
Net Income
Title
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Total Revenue 10,829 17,931 8,886 19,615
Gross Profit 7,591 12,390 6,202 13,001
Operating Income 3,042 3,613 2,058 4,033
Net Income 2,317 2,776 1,566 3,033
Clear All
0Selected
Please try another search
SNY
Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
Total Assets
Total Liabilities
Title
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Total Assets 112,321 114,529
Total Liabilities 49,084 51,528
Total Equity 63,237 63,001
Clear All
0Selected
Please try another search
SNY
Cash Flow/Share TTM 3.5
Revenue/Share TTM 17.39
Operating Cash Flow -
Cash
Net Change in Cash
Title
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Cash From Operating Activities 4,754 7,449
Cash From Investing Activities -2,339 3,588
Cash From Financing Activities -6,616 -6,485
Net Change in Cash -4,193 4,488
Clear All
0Selected
Please try another search

* In Millions of EUR (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.